drugset / Trial / NCT06370442

Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult

NCT06370442

RandomizedParallel-groupDouble-blindSupportive care

Summary

The purpose of the study is to determine if intranasal dexmedetomidine could be an alternative to the current standard of care (injectable benzodiazepines or antipsychotics) for sedation prior to computerized tomography (CT) or magnetic resonance imaging (MRI) in those greater than or equal to 65 years of age (older adults) that are seen in the Emergency Department (ED).

Timeline

Start
2024-06-01
Primary completion
2025-05-31
Completion
2025-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 100 ug Intranasal
Comparator Haloperidol Other / unclassified 0.5 mg Intravenous
Comparator Lorazepam Small molecule 0.5 mg Intravenous

Indications